Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Arsenic Trioxide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioSenic Analyzes Phase 2 Data For Arsenic Trioxide In CGVHD Trial
    BioSenic Analyzes Phase 2 Data For Arsenic Trioxide In CGVHD Trial

    18 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/18/2915008/0/en/BioSenic-releases-new-in-depth-analysis-of-its-positive-phase-2-clinical-data-for-optimal-administration-scheme-for-its-next-late-stage-trial-of-arsenic-trioxide-ATO-targeting-cGvH.html

    GLOBENEWSWIRE
    18 Jul 2024
    Share Share
    Medsenic, subsidiary of BioSenic SA, extends key patent to the United States
    Medsenic, subsidiary of BioSenic SA, extends key patent to the United States

    05 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/05/2908872/0/en/Medsenic-subsidiary-of-BioSenic-SA-extends-key-patent-to-the-United-States.html

    GLOBENEWSWIRE
    05 Jul 2024
    Share Share
    Medsenic Signs New Licensing Agreements With Phebra PTY Ltd
    Medsenic Signs New Licensing Agreements With Phebra PTY Ltd

    02 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/02/2907129/0/en/Medsenic-BioSenic-s-subsidiary-signed-a-new-set-of-licensing-and-commercialization-agreements-with-Phebra-PTY-Ltd.html

    GLOBENEWSWIRE
    02 Jul 2024
    Share Share
    Medsenic amends licence agreement with Phebra for arsenic trioxide
    Medsenic amends licence agreement with Phebra for arsenic trioxide

    30 May 2023

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/medsenic-licence-phebra-oato/

    PHARMACEUTICAL TECHNOLOGY
    30 May 2023
    Share Share
    BioSenic SA provides update on its autoimmune disease platform based on ATO
    BioSenic SA provides update on its autoimmune disease platform based on ATO

    07 Nov 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/11/08/2550394/0/en/BioSenic-SA-provides-update-on-its-autoimmune-disease-platform-based-on-ATO-arsenic-trioxide.html

    GLOBENEWSWIRE
    07 Nov 2022
    Share Share
    Medsenic Publishes an Article in Transplantation and Cellular Therapy
    Medsenic Publishes an Article in Transplantation and Cellular Therapy

    18 Jul 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220718005461/en

    BUSINESSWIRE
    18 Jul 2022
    Share Share